Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Gabapentin NDC 63304-628 by Ranbaxy Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

contain100 - contain100

contain100 - contain100

This is a medication called Gabapentin, which comes in capsule form. Pharmacists should provide the accompanying medication guide to each patient who receives this prescription. The NDC number for this medication is 63304-627-0. It is only available with a prescription.*

300 mg bottle label - contain300

300 mg bottle label - contain300

This is a prescription drug called Gabapentin capsules, which come in a bottle of 100 capsules. The pharmacist is advised to dispense a Medication Guide to each patient who receives this drug.*

contain400 - contain400

contain400 - contain400

This is a medication called Gabapentin, in the form of capsules. It is only available with a prescription, and it comes with a medication guide that should be given to each patient by the pharmacist. The quantity mentioned is 100 capsules.*

Figure 1 - figure1

Figure 1 - figure1

The text provides information about mean pain score, with a value of 10. There are references to "Voo Dos Trsion Paied," "Oplacebs," and "Gabapantin, 3800 moiday," which suggest that the data may come from a study or clinical trial evaluating pain relief treatments. There is also a table or graph with columns labeled "Bidbe," "4," "3," "A," "s," and "1," but it is unclear what this information represents. Overall, without further context it is difficult to provide a more detailed description.*

figure 2 - figure2

figure 2 - figure2

This appears to be a chart or graph displaying the dosing regimen for two different periods of gabapentin treatment, one 3-week dose titration period and one 8-week fixed dose period. The chart displays the dosage amount in milligrams per day, increasing from 1800 mg/day to 2400 mg/day during the titration period. The chart is labeled with a scale counting weeks.*

figure 3 - figure3

figure 3 - figure3

The text seems to be a chart displaying the percentage of responders at an endpoint for Study 1 and Study 2. The chart appears to show that Study 1 had a higher percentage of responders at the endpoint compared to Study 2. The text does not provide any details about what the study is about or what the endpoint is.*

figure 4 - figure4

figure 4 - figure4

mstructure - mstructure

mstructure - mstructure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.